« Back to Research Deepdives

Are Probiotics Effective for Irritable Bowel Syndrome?

This content is restricted to members.

To view our premium content, sign up for a membership:

Register New Account

Username

First Name

Last Name

Password

Password Again

Choose your membership level

Monthly Membership - €24.99 - 1 Month
Full Education Hub access: the weekly Study Deepdive, bi-monthly video Research Lectures, Exclusive Articles, and the full backcatalog of Deepdives in downloadable pdf format.
Annual Membership - €249.99 - 1 Year
Access to all the Education Hub content, at a reduced annual rate.

Discount Code - Valid - Invalid

Choose Your Payment Method

Credit / Debit Card PayPal

I agree to the privacy policy

‹ Back to Research Deepdives

References

Hill C, Guarner F, Reid G, Gibson GR, Merenstein DJ, Pot B, et al. The International Scientific Association for Probiotics and Prebiotics consensus statement on the scope and appropriate use of the term probiotic. Nat Rev Gastroenterol Hepatol. 2014 Aug 10;11(8):506–14.
Fijan S. Microorganisms with Claimed Probiotic Properties: An Overview of Recent Literature. Int J Environ Res Public Health. 2014 May 5;11(5):4745–67.
Ritchie ML, Romanuk TN. A Meta-Analysis of Probiotic Efficacy for Gastrointestinal Diseases. PLoS One. 2012 Apr 18;7(4):e34938.
McFarland L V. Meta-Analysis of Probiotics for the Prevention of Antibiotic Associated Diarrhea and the Treatment of Clostridium difficile Disease. Am J Gastroenterol. 2006 Apr;101(4):812–22.
Szajewska H, Mrukowicz J. Meta-analysis: non-pathogenic yeast Saccharomyces boulardii in the prevention of antibiotic-associated diarrhoea. Aliment Pharmacol Ther. 2005 Sep;22(5):365–72.
Rajilić-Stojanović M, Jonkers DM, Salonen A, Hanevik K, Raes J, Jalanka J, et al. Intestinal Microbiota And Diet in IBS: Causes, Consequences, or Epiphenomena? American Journal of Gastroenterology. 2015 Feb;110(2):278–87.
Staudacher HM, Lomer MCE, Anderson JL, Barrett JS, Muir JG, Irving PM, et al. Fermentable Carbohydrate Restriction Reduces Luminal Bifidobacteria and Gastrointestinal Symptoms in Patients with Irritable Bowel Syndrome. J Nutr. 2012 Aug;142(8):1510–8.
McFarland L V., Evans CT, Goldstein EJC. Strain-Specificity and Disease-Specificity of Probiotic Efficacy: A Systematic Review and Meta-Analysis. Front Med (Lausanne). 2018 May 7;5.
Zhang Y, Li L, Guo C, Mu D, Feng B, Zuo X, et al. Effects of probiotic type, dose and treatment duration on irritable bowel syndrome diagnosed by Rome III criteria: a meta-analysis. BMC Gastroenterol. 2016 Dec 13;16(1):62.
Majeed M, Nagabhushanam K, Arumugam S, Majeed S, Ali F. Bacillus coagulans MTCC 5856 for the management of major depression with irritable bowel syndrome: a randomised, double-blind, placebo controlled, multi-centre, pilot clinical study. Food Nutr Res. 2018 Jul 4;62(0).
Majeed M, Nagabhushanam K, Paulose S, Arumugam S, Mundkur L. The effects of Bacillus coagulans MTCC 5856 on functional gas and bloating in adults: A randomized, double-blind, placebo-controlled study. Medicine. 2023 Mar 3;102(9):e33109.
McKenzie YA, Thompson J, Gulia P, Lomer MCE. British Dietetic Association systematic review of systematic reviews and evidence-based practice guidelines for the use of probiotics in the management of irritable bowel syndrome in adults (2016 update). Journal of Human Nutrition and Dietetics. 2016 Oct;29(5):576–92.
Vasant DH, Paine PA, Black CJ, Houghton LA, Everitt HA, Ford AC. British Society of Gastroenterology guidelines on the management of irritable bowel syndrome . BMJ Gut. 2021 Apr 26;70(7):1214–40.